These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol. Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974 [TBL] [Abstract][Full Text] [Related]
8. A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial. Chaudhry IB; Husain N; ur Rahman R; Husain MO; Hamirani MM; Kazmi A; Baig S; Haddad PM; Buch MH; Qureshi I; Mehmood N; Kiran T; Fu B; Afsar S; Deakin B Trials; 2015 Jan; 16():9. PubMed ID: 25563714 [TBL] [Abstract][Full Text] [Related]
9. Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial. Dean OM; Kanchanatawan B; Ashton M; Mohebbi M; Ng CH; Maes M; Berk L; Sughondhabirom A; Tangwongchai S; Singh AB; McKenzie H; Smith DJ; Malhi GS; Dowling N; Berk M Aust N Z J Psychiatry; 2017 Aug; 51(8):829-840. PubMed ID: 28578592 [TBL] [Abstract][Full Text] [Related]
10. Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials. Zazula R; Husain MI; Mohebbi M; Walker AJ; Chaudhry IB; Khoso AB; Ashton MM; Agustini B; Husain N; Deakin J; Young AH; Berk M; Kanchanatawan B; Ng CH; Maes M; Berk L; Singh AB; Malhi GS; Dean OM Aust N Z J Psychiatry; 2021 Aug; 55(8):784-798. PubMed ID: 33092404 [TBL] [Abstract][Full Text] [Related]
11. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
12. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial. Husain MI; Chaudhry IB; Hamirani MM; Minhas FA; Kazmi A; Hodsoll J; Haddad PM; Deakin JF; Husain N; Young AH Neuropsychiatr Dis Treat; 2017; 13():1-8. PubMed ID: 28031712 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Fourrier C; Sampson E; Mills NT; Baune BT Trials; 2018 Aug; 19(1):447. PubMed ID: 30126458 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial. Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851 [TBL] [Abstract][Full Text] [Related]
15. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder. Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836 [TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression. Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355 [TBL] [Abstract][Full Text] [Related]
17. CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial. Overend K; Lewis H; Bailey D; Bosanquet K; Chew-Graham C; Ekers D; Gascoyne S; Hems D; Holmes J; Keding A; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Parrott S; Richards D; Traviss G; Trépel D; Woodhouse R; Gilbody S Trials; 2014 Nov; 15(1):451. PubMed ID: 25409776 [TBL] [Abstract][Full Text] [Related]
18. Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study). McAllister-Williams RH; Smith E; Anderson IM; Barnes J; Gallagher P; Grunze HC; Haddad PM; House AO; Hughes T; Lloyd AJ; McColl EM; Pearce SH; Siddiqi N; Sinha B; Speed C; Steen IN; Wainright J; Watson S; Winter FH; Ferrier IN BMC Psychiatry; 2013 Aug; 13():205. PubMed ID: 23914988 [TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. Yang C; Bosker FJ; Li J; Schoevers RA BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835 [TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder. Umbricht D; Niggli M; Sanwald-Ducray P; Deptula D; Moore R; Grünbauer W; Boak L; Fontoura P J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32663909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]